Trial of Early Antiviral Therapies during Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19: a summary of the protocol and analysis plan for a decentralized randomized controlled trial
DiscussionIf effective treatments for COVID-19 can be identified for individuals in the outpatient setting before they advance to severe disease, it will prevent progression to more severe disease, reduce the need for hospitalization, and shorten the duration of symptoms. The novel decentralized, “no touch” approach used by the TREAT NOW platform has distinction advantages over traditional in-person trials to reach broader populations and perform study procedures in a pragmatic yet rigorous manner.Trial registrationClinicalTrials.gov NCT04372628. Registered on April 30, 2020. First posted on May 4, 2020. (Source: Trials)
Source: Trials - April 8, 2022 Category: Research Source Type: clinical trials
Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19
Condition: Efficacy and Safety of Monotherapy and Polytherapy of Enaxoprin and Hydroxychloroquine Intervention: Drug: Enoxaparin, Hydroxychloroquine Sponsor: Beni-Suef University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2022 Category: Research Source Type: clinical trials
Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19
Condition: COVID-19 Pandemic Intervention: Drug: Enoxaparin, Hydroxychloroquine Sponsor: Beni-Suef University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2022 Category: Research Source Type: clinical trials
The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia
Condition: Preeclampsia Intervention: Drug: Hydroxychloroquine Sponsors: Yoo-min Kim; Ministry of Health & Welfare, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials
